2012

1. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: Results from a pivotal phase III study

   Menopause, Vol. 19, Núm. 10, pp. 1130-1139